AUDITORIUM • NIVEAU - 1
|
|
Friday January 22, morning |
|
| 08.30 | Lower Limb Occlusive Disease - Session endorsed by the  |
|||
| Chairmen | Alan Dardik, Koen Deloose, Yann Gouëffic, Peter Schneider | |||
| What you need to know to perform successful peripheral repair | ||||
| 08.30 | Why duplex scans should be mastered by vascular surgeons, Enrico Ascher | |||
| 08.40 | Drug eluted balloons. Concepts, products and how to use them, George Papandreou | |||
| 08.50 | After one year, what are the results of DES? Koon Keirse | |||
| 09.00 | Drug coated balloons. What are the specificities and clinical results, Frank Vermassen | |||
| 09.10 | In stent restenosis: is DCB the ultimate tool? Giovanni Torsello | |||
| 09.20 | What does "stent’s radial force" mean? Marc Bosiers | |||
| 09.30 | DES: what happen after 5 years. Are DES still better than bare stents? Michael Dake | |||
| 09.40 | DES versus recent bare stents: is the drug more efficient than a placebo? Yann Gouëffic | |||
| 09.50 | Discussion | |||
| 10.00 | Break in the exhibition hall  |
|||
| 10.30 | Challenges in Lower Limb Endovascular Repair: How to Break the Limits | |||
| Chairman | Ali Amin, Michael Dake, Eric Ducasse, Peter Goverde | |||
| 10.30 | One day surgery for endovascular repair: basic requirements and patient’s selection. US experience, Peter Schneider |
|||
| 10.40 | SFA long lesions: which one can be treated endo and how? Koen Deloose | |||
| 10.50 | BTK lesions: DEB or DES? Roberto Ferraresi | |||
| 11.00 | Tibial arteries repair: when and how, Peter Schneider | |||
| 11.10 | What can be expected of tibial repair in diabetic patients, Daniel Brandao | |||
| 11.20 | Ankle approaches: material, techniques and some results, Roberto Ferraresi | |||
| 11.30 | Is there a role for distal bypass in the endovascular era: lessons learnt from 15.000 procedures, Clement Darling |
|||
| 11.40 | Bypass in the leg after failed endo repair. Do the results compare to first line bypass? Julien Sfeir | |||
| 11.50 | Follow-up of patients treated by prosthetic bypass of the lower limb, cost model evaluation at two years, Yann Gouëffic | |||
| 12.00 | Discussion | |||
| 12.05 | Industry symposia | |||
| 13.05 | Lunch in the exhibition hall  |
AUDITORIUM • NIVEAU - 1
|
|
Friday January 22, afternoon
|
|
| 14.00 | Aortic Occlusive Disease |
|||
| Chairmen & experts |
Martin Malina, Gustavo Oderich, Grzegorz Oszkinis, Giovanni Torsello | |||
| Duel. Totally occluded aorta | ||||
| 14.00 | Open surgery is the norm, Myke Wyatt | |||
| 14.10 | Open surgery is a major and unnecessary aggression, Martin Malina | |||
| 14.20 | Discussion | |||
| 14.40 | Landscape of error in aortic procedure, Colin Bicknell | |||
| 14.50 | Mistakes can have a heavy toll. What you must know to avoid defeat, Isabelle Lucas Baloup | |||
| 15.00 | Discussion | |||
| 15.10 | Cases selected by Jean-Pierre Becquemin for world experts opinion |
|||
| 15.40 | Carotid - PART I | |||
| 15.40 | Not all stenoses are at risk of stroke. Which ones should not be missed? Stavros Kakkos |
|||
| Duel. There is no need for a new trial comparing intervention and medical treatment for carotid stenoses |
||||
| 15.50 | For the motion, Réda Hassen-Khodja | |||
| 16.00 | Against the motion, Jean-Louis Mas | |||
| 16.10 | Discussion | |||
| 16.20 | Break in the exhibition hall |
|||
| 16.50 | Carotid - PART II | |||
| Chairmen | Mohamed Bouayed, Hans-Henning Eckstein, Michel Makaroun, Ross Naylor | |||
| 16.50 | ACST 2: 2.000 patients randomized. What are the lessons? Alison Halliday | |||
| 17.00 | Is plaque morphology a predictor of neurological complication after CAS or CEA? Wesley Moore | |||
| 17.10 | Discussion | |||
| 17.20 | Honor guest lecture. The lost tribe, Ross Naylor | |||
| Some tricks to improve CAS results | ||||
| 17.30 | The use of advanced imaging tools, Koen Deloose | |||
| 17.40 | The use of proximal protection and mesh covered stents, Peter Schneider | |||
| 17.50 | Can CAS improve cognitive function? Christos Liapis | |||
| 18.00 | Discussion | |||
| How to improve CEA | ||||
| 18.10 | By using simple but often ignored rules, Carlo Pratesi | |||
| 18.20 | Surgery is safe after an acute stroke, Gustav Fraedrich | |||
| 18.40 | Discussion | |||
| 19.00 | End of the session |
ROOM B • NIVEAU - 1
|
|
Friday January 22, afternoon
|
|
| 14.00 | Flash news. The Latest of EVAR Technology |
|||
| Chairmen | Alan Dardik, Pascal Desgranges, Roger Greenhalgh, Willem Wisselink | |||
| 14.00 | PTFe grafts, Marc Van Sambeek | |||
| 14.10 | Do low profile grafts compromise durability? Sonia Ronchey | |||
| 14.20 | 5 year results of a new generation device, Michel Makaroun | |||
| 14.30 | Why stopping the follow up put your patients at risk? Michel Bartoli | |||
| 14.40 | How do the French Engage study compared with international registry? Maxime Raux | |||
| 14.50 | Discussion | |||
| 15.00 | Ruptured AAA - Session endorsed by the |
|||
| Duel. Is the debate about ruptured aneurysms treatment over? | ||||
| 15.00 | Open surgery is as good as endo: lessons from IMPROVE trial, Janet Powell | |||
| 15.10 | Forget the knife: EVAR is a most valuable option in all ruptures, Frank Veith | |||
| 15.20 | Discussion | |||
| 15.30 | Local anesthesia for ruptured AAA. One key to improve survival? Jan Heyligers | |||
| 15.40 | Standard EVAR is not applicable in all rupture cases: what are my tricks to treat 100% rupture cases endo? Mario Lachat | |||
| 15.50 | Discussant, Claude Angel | |||
| 15.55 | Open repair for rupture: recent tricks which have improved the results, Adel Khayati | |||
| 16.05 | Discussion | |||
| 16.10 | Break in the exhibition hall |
|||
| 16.40 | How Can We Improve the Results of EVAR | |||
| Chairmen | Eric Allaire, Clement Darling, Ian Loftus, Fabio Verzini | |||
| The dead space in AAA sac is the ultimate enemy | ||||
| 16.40 | Concept and new graft design to overcome the issue, Fabien Koskas | |||
| 16.50 | EVAS: any doubt left after more than 300 procedures and the European register? Ian Loftus | |||
| 17.00 | Discussion | |||
| How to improve results and cost of EVAR | ||||
| 17.10 | Preoperative use of an electronic simulator, Jean-Nöel Albertini | |||
| 17.20 | Hypnosis for endovascular interventions: an overview, Véronique Mercier | |||
| 17.27 | Hypnosis for EVAR: it works! Can you believe it? Asmaa Khaled | |||
| 17.35 | Fascia suture is cheaper than preclosing device but is it as safe? Thomas Larzon | |||
| 17.45 | Can endostappling improve the results of EVAR? Jean-Paul de Vries | |||
| 17.55 | Thrombus lining in an EVAR stent graft: is it harmful, should it be treated? Hence Verhagen | |||
| 18.05 | Appraisal of current societies guidelines to follow all EVAR patients, Roger Greenhalgh | |||
| 18.15 | Why stopping the follow up put your patients at risk, Michel Bartoli | |||
| 18.25 | What are the specific requirements and results of EVAR in Japanese patients? Kimihiro Komori | |||
| 18.35 | Discussion | |||
| 18.45 | New tools for clinical research studies, Fabien Leclercq | |||
| 18.55 | End of the session |
 |
Simultaneous translation : Headphones will be available on request (only if a valid ID is presented) when entering the room. |